(Total Views: 763)
Posted On: 05/19/2020 11:23:34 AM
Post# of 148903
If anyone is interested in learning about coronavirus and development of Remdesivir, I recommend this pod cast:
https://www.npr.org/podcasts/381444414/the-pe...io-program
MAY 7, 2020
Show 1211: A Conversation With the Coronavirus Hunter
Dr. Ralph Baric has been studying coronaviruses for 35 years and is one of the world's leading experts on these pathogens. In this interview, you will learn how the virus jumped from bats to people and how it replicates. Moreover, Dr. Baric was already studying remdesivir, a medication being utilized against this infection. He will explain how it works and why another drug may be even better.
Remdesivir is injectable, so doctors administer it only in a hospital setting. Dr. Baric's group and their colleagues at Emory University and elsewhere have been developing an oral medication, EIDD-2801. Dr. Baric refers to it as NHC, and he explains how it is similar to and how it differs from remdesivir.
https://www.genengnews.com/covid-19-candidate...ory-drive/
There are many, many drugs being studied, so when President or Fauci mentions an antibody drug, imo, the odds that it is leronlimab are low.
At least, in this link Cytodyn is listed as one of many frontrunners:
https://www.genengnews.com/category/covid-19-candidates/
https://www.npr.org/podcasts/381444414/the-pe...io-program
MAY 7, 2020
Show 1211: A Conversation With the Coronavirus Hunter
Dr. Ralph Baric has been studying coronaviruses for 35 years and is one of the world's leading experts on these pathogens. In this interview, you will learn how the virus jumped from bats to people and how it replicates. Moreover, Dr. Baric was already studying remdesivir, a medication being utilized against this infection. He will explain how it works and why another drug may be even better.
Remdesivir is injectable, so doctors administer it only in a hospital setting. Dr. Baric's group and their colleagues at Emory University and elsewhere have been developing an oral medication, EIDD-2801. Dr. Baric refers to it as NHC, and he explains how it is similar to and how it differs from remdesivir.
https://www.genengnews.com/covid-19-candidate...ory-drive/
There are many, many drugs being studied, so when President or Fauci mentions an antibody drug, imo, the odds that it is leronlimab are low.
At least, in this link Cytodyn is listed as one of many frontrunners:
https://www.genengnews.com/category/covid-19-candidates/
(0)
(0)Scroll down for more posts ▼
